Cortex Medipharma Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 02-01-2025
- Paid Up Capital ₹ 0.20 M
as on 02-01-2025
- Company Age 13 Year, 10 Months
- Last Filing with ROC 31 Mar 2021
- Revenue -17.66%
(FY 2021)
- Profit 86.14%
(FY 2021)
- Ebitda 93.99%
(FY 2021)
- Net Worth 14.30%
(FY 2021)
- Total Assets 13.66%
(FY 2021)
About Cortex Medipharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Nagaraj Vardhaman and Manjula Vardhaman serve as directors at the Company.
- CIN/LLPIN
U74990KA2011PTC057346
- Company No.
057346
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Mar 2011
- Date of AGM
03 Jan 2022
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Cortex Medipharma Private Limited offer?
Cortex Medipharma Private Limited offers a wide range of products and services, including Health Conditions, Menopause.
Who are the key members and board of directors at Cortex Medipharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nagaraj Vardhaman  | Director | 03-Mar-2011 | Current |
| Manjula Vardhaman | Director | 22-Mar-2017 | Current |
Financial Performance of Cortex Medipharma.
Cortex Medipharma Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 17.66% decrease. The company also saw a substantial improvement in profitability, with a 86.14% increase in profit. The company's net worth Soared by an impressive increase of 14.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cortex Medipharma?
In 2021, Cortex Medipharma had a promoter holding of 96.00% and a public holding of 4.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cortex Medipharma?
Unlock and access historical data on people associated with Cortex Medipharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cortex Medipharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cortex Medipharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
